Pacira BioSciences (NASDAQ:PCRX – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday. Other research analysts also recently issued research reports about the stock. Weiss Ratings raised shares of Pacira BioSciences from a “sell (d)” rating to [...]